Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Early T-cell responses in tuberculosis immunity.

Winslow GM, Cooper A, Reiley W, Chatterjee M, Woodland DL.

Immunol Rev. 2008 Oct;225:284-99. doi: 10.1111/j.1600-065X.2008.00693.x. Review.

3.

Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.

Stylianou E, Diogo GR, Pepponi I, van Dolleweerd C, Arias MA, Locht C, Rider CC, Sibley L, Cutting SM, Loxley A, Ma JK, Reljic R.

Eur J Immunol. 2014 Feb;44(2):440-9.

4.

The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.

Roche CM, Smith A, Lindsey DR, Meher A, Schluns K, Arora A, Armitige LY, Jagannath C.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S96-104. doi: 10.1016/j.tube.2011.10.018.

5.

DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.

Dalmia N, Klimstra WB, Mason C, Ramsay AJ.

PLoS One. 2015 Aug 28;10(8):e0136635. doi: 10.1371/journal.pone.0136635.

6.
7.

Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.

Billeskov R, Grandal MV, Poulsen C, Christensen JP, Winther N, Vingsbo-Lundberg C, Hoang TT, van Deurs B, Song YH, Aagaard C, Andersen P, Dietrich J.

Eur J Immunol. 2010 May;40(5):1342-54. doi: 10.1002/eji.200939830. Erratum in: Eur J Immunol. 2011 Mar;41(3):873.

8.

Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.

Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR.

Eur J Immunol. 2008 Mar;38(3):695-705. doi: 10.1002/eji.200737888.

9.
10.

A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.

Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, Fan X.

Appl Microbiol Biotechnol. 2015 Dec;99(24):10587-95. doi: 10.1007/s00253-015-6962-x.

PMID:
26363555
12.

Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.

Siddiqui KF, Amir M, Khan N, Rama Krishna G, Sheikh JA, Rajagopal K, Agrewala JN.

Clin Exp Immunol. 2015 Aug;181(2):286-96. doi: 10.1111/cei.12634.

13.

Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Rahman S, Magalhaes I, Rahman J, Ahmed RK, Sizemore DR, Scanga CA, Weichold F, Verreck F, Kondova I, Sadoff J, Thorstensson R, Spångberg M, Svensson M, Andersson J, Maeurer M, Brighenti S.

Mol Med. 2012 May 9;18:647-58. doi: 10.2119/molmed.2011.00222.

14.

Antigens for CD4 and CD8 T cells in tuberculosis.

Lindestam Arlehamn CS, Lewinsohn D, Sette A, Lewinsohn D.

Cold Spring Harb Perspect Med. 2014 May 22;4(7):a018465. doi: 10.1101/cshperspect.a018465. Review.

16.

An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.

Cayabyab MJ, Qin L, Kashino SS, Izzo A, Campos-Neto A.

Vaccine. 2013 Oct 1;31(42):4834-40. doi: 10.1016/j.vaccine.2013.07.077.

17.

Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.

Lu M, Xia ZY, Bao L.

Cell Immunol. 2013 Sep-Oct;285(1-2):111-7. doi: 10.1016/j.cellimm.2013.10.001.

PMID:
24177251
18.

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.

Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR.

J Immunol. 2001 May 15;166(10):6227-35.

19.

Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.

Wang X, Zhang J, Liang J, Zhang Y, Teng X, Yuan X, Fan X.

PLoS One. 2015 Mar 30;10(3):e0122560. doi: 10.1371/journal.pone.0122560.

20.

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.

Skeiky YA, Ovendale PJ, Jen S, Alderson MR, Dillon DC, Smith S, Wilson CB, Orme IM, Reed SG, Campos-Neto A.

J Immunol. 2000 Dec 15;165(12):7140-9.

Items per page

Supplemental Content

Support Center